Basic and Translational Research on Antitumor Drugs Promotes Clinical Therapy

Malignant tumors have emerged as a significant public health problem, posing a grave threat to the human health. With the development of medical technology, the survival rate of tumor patients has shown remarkable improvement. However, the existing treatment strategies are far from meeting the clinical needs, and problems are still existed such as few available drugs and serious adverse reactions. To further advance the clinical treatment of tumor patients, this issue presents the column of “Antitumor Drug Research and Translation”, which is divided into two major topics, “the discovery of antitumor drug target and lead compound” and “intelligent delivery of antitumor drugs for translation research”. This column aims to provide novel drug targets and therapeutic strategies for the clinical treatment of tumor patients, thereby boosting the development of innovative anti-tumor drugs.